ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
19 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
978
|
265K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
11 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
27K
|
11
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
10 |
2.0K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
10
|
2.0K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose to Commence Drilling at Rana Project, Norway
|
|
NZ Trader
|
15 |
4.6K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
15
|
4.6K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
10 |
2.0K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
10
|
2.0K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
832 |
330K |
5 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
832
|
330K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
832 |
330K |
10 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
832
|
330K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
12 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
117
|
30K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
13 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
27K
|
13
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
NZ Trader
|
36 |
9.6K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.6K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
22 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
39 |
10K |
4 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
NZ Trader
|
36 |
9.6K |
3 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.6K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
8 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
35 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
27K
|
35
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
10 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
16 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
16
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
NZ Trader
|
36 |
9.6K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.6K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
8 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
117
|
30K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
22 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
7 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
10 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
15
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
117
|
30K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
NZ Trader
|
297 |
85K |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
297
|
85K
|
15
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
39 |
10K |
6 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
39
|
10K
|
6
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Quarterly Activities Report /Appendix 4C Cash Flow Statement
|
|
NZ Trader
|
1 |
811 |
1 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
1
|
811
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
39 |
10K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
39
|
10K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
28 |
9.6K |
5 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
28
|
9.6K
|
5
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
28 |
9.6K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
28
|
9.6K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
CDH17 Car T therapy has blockbuster potential
|
|
NZ Trader
|
8 |
3.0K |
6 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
8
|
3.0K
|
6
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
28 |
9.6K |
3 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
28
|
9.6K
|
3
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM RECEIVES APPROVAL FOR DRILLING AT THE PORSANGER PROJECT
|
|
NZ Trader
|
78 |
19K |
1 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
78
|
19K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
12 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
117
|
30K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
CDH17 Car T therapy has blockbuster potential
|
|
NZ Trader
|
8 |
3.0K |
10 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
8
|
3.0K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
NZ Trader
|
157 |
46K |
5 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
157
|
46K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
30 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
978
|
265K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
NZ Trader
|
111 |
38K |
23 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
111
|
38K
|
23
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose Appoints New Chief Financial Officer
|
|
NZ Trader
|
1 |
1.0K |
11 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
1
|
1.0K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
NZ Trader
|
69 |
21K |
10 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
69
|
21K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
286 |
67K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
286
|
67K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
NZ Trader
|
69 |
21K |
9 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
69
|
21K
|
9
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
NZ Trader
|
69 |
21K |
14 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
69
|
21K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
832 |
330K |
5 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
832
|
330K
|
5
|
|